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Objectives: The study objectives were to describe the aortic histopathologic sub-
strates in patients with type A surgically treated acute aortic syndromes, to pro-
vide clinico-pathological correlations, and to identify the possible prognostic
role of histology.
Methods:We assessed the aortic wall degenerative or inflammatory alterations of
158 patients according to the histopathologic consensus documents. Moreover,
we correlated these histologic patterns with the patients’ clinical data and long-
term follow-up for mortality, major aorta-related events, and nonaorta-related
events (including cardiovascular ones).
Results:We identified 2 histopathologic patterns: 122 patients (77%) with degen-
erative alterations and 36 patients (23%) with mixed degenerative-atherosclerotic
lesions. Patients with mixed alterations were older (mean 69.6  8.7 years vs
62.2  12.4 years, P ¼ .001) and more hypercholesterolemic (33.3% vs
13.9%, P ¼ .017). The degenerative subgroup showed more intralamellar-
mucoid extracellular matrix accumulation (86% vs 66.7%, P¼ .017) and a lower
prevalence of translamellar collagen increase (9.8% vs 50%, P<.001). Patients
with mixed degenerative-atherosclerotic abnormalities more frequently had
long-term nonaorta-related events compared with those with degenerative
abnormalities alone (P ¼ .046); no differences were found between the groups
with respect to mortality, major aorta-related events, and cardiovascular
nonaorta-related events.
Conclusions: Although degenerative lesions of the medial layer were present in
all specimens, substantial atherosclerosis coexisted in approximately one quarter
of cases. Patients with mixed degenerative-atherosclerotic abnormalities had a
coherent clinical risk profile, a clinical presentation frequently mimicking acute
coronary syndrome, and a higher incidence of nonaorta-related events during
follow-up. Histopathologic characterization may improve the long-term prog-
nostic stratification of patients after surgical treatment. (J Thorac Cardiovasc
Surg 2018;156:1776-85)From the aDepartment of Pathology, Sant’Orsola-Malpighi University Hospital,
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Central Message
Patients with relevant atherosclerosis associ-
ated with MD were older, hypercholesterol-
emic, and had more major nonaorta-related
events than patients without atherosclerosis.Perspective
All surgical specimens of type A AAS showed
MD, associated with relevant atherosclerosis in
one quarter. These patients had a coherent CV
risk profile and showed more nonaorta-related
events. Atherosclerosis was a probable inde-
pendent risk factor for nonaorta-related events.
Therefore, histology holds a stronger predictive
value than clinical data alone.See Editorial Commentary page 1786.
See Editorial page 1772.io Rapezzi, MD, Cardiology, Department of Experimental
alty Medicine, Alma Mater Studiorum-University of
renti 9, Bologna 40138, Italy (E-mail: claudio.rapezzi@




AAS ¼ acute aortic syndrome
ACS ¼ acute coronary syndrome
AECVP ¼ Association for European
Cardiovascular Pathology
CI ¼ confidence interval
CV ¼ cardiovascular
EFFL ¼ elastic fiber fragmentation/loss
EFT ¼ elastic fiber thinning out
HR ¼ hazard ratio
ICI ¼ intralamellar collagen increase
I-MEMA ¼ intralamellar mucoid extracellular
matrix accumulation
LMC ¼ laminar medial collapse
MD ¼ medial degeneration
SCVP ¼ Society for Cardiovascular Pathology
TCI ¼ translamellar collagen increase
T-MEMA ¼ translamellar mucoid extracellular
matrix accumulation
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Type A acute aortic syndromes (AAS) are a life-threatening
condition that require emergency surgical treatment.1
Although different inherited and acquired conditions pre-
dispose to this dramatic event, our knowledge of the histol-
ogy of the diseased aortic wall is incomplete. The available
clinico-pathological correlation studies are relatively old
and tend to examine acute and chronic aortic diseases
together.2-5
The histopathology underlying type A AAS is gener-
ally considered due to degenerative lesions of the aortic
medial layer, first identified by Erdheim6 in 1930 as
‘‘aortic idiopathic (cystic) medial necrosis.’’ Recently,
however, the Association for European Cardiovascular
Pathology (AECVP) and the Society for Cardiovascular
Pathology (SCVP) have proposed a revised nomen-
clature, terminology, grading systems, and diagnostic
criteria for aortic diseases in 2 consensus statements on
the histopathology of inflammatory7 and noninflamma-
tory degenerative8 aortic diseases. We applied these
criteria to the analysis of the aortic specimens obtained
during surgery, with the aim of providing detailed histo-
pathologic characterization and search for clinico-
pathological correlations, including the possible role of
histology in prognostic stratification.The Journal of Thoracic and CarMATERIALS AND METHODS
Clinical Setting
Our hospital is the AAS referral center for Bologna and the surrounding
metropolitan area (catchment area 1,000,000 inhabitants). Our registry in-
cludes all adult (aged>18 years) consecutive patients with a final diagnosis
of spontaneous AAS referred to our center between January 1, 2000, and
December 31, 2013. Patients with symptoms onset lasting more than
14 days or with traumatic AAS were not included. Median follow-up for
alive patients was 4 years (interquartile range, 2.2-6). The study conforms
to the principles outlined in the Declaration of Helsinki and was approved
by the local ethics committee, and patients provided written informed
consent.
Pathology
An average of 6 samples were obtained from ascending aortic specimens
of patients operated for type AAAS and paraffin embedded (Figure E1). The
histologic sections were stained with hematoxylin–eosin and stainings for
collagen (Azan–Mallory trichrome) and elastic fibers (Weigert–VanGieson).
The samples were evaluated de novo, blind to clinical data, applying the
AECVP/SCVP documents diagnostic criteria.7,8
Degenerative aortic medial damage was assessed as overall medial
degeneration (MD) resulting from the sum of 6 individual abnormalities:
mucoid extracellular matrix accumulation (MEMA), both intralamellar
(I-MEMA) and translamellar (T-MEMA); elastic fiber fragmentation/loss
(EFFL); elastic fiber thinning out (EFT); laminar medial collapse
(LMC); intralamellar collagen increase (ICI); and translamellar collagen
increase (TCI). Overall MD was graded as mild, moderate, or severe,
considering both severity and distribution of single abnormalities.
Atherosclerotic plaques were described according to the American
Heart Association scheme.9,10 Atherosclerosis was then graded as not
significant, mild, moderate, or severe. Only moderate to severe lesions
were considered causative of significant medial damage.
Clinical Definitions
Major aorta-related events were defined as rehospitalizations for the
following aortic complications in some cases requiring reintervention: or-
gan malperfusion, increasing aortic diameter, progressive false lumen
dilation, aortic rupture, redissection, and moderate/severe aortic
regurgitation.
Nonaorta-related events were defined as rehospitalizations for other CV
causes (including acute coronary syndrome [ACS], congestive heart fail-
ure, arrhythmia, cerebrovascular accident, bleeding, and other CV causes)
and rehospitalization for non-CV causes, mainly neoplasms and infections.
Sudden death was considered aorta related in cases of aortic rupture
documented on postmortem or when preceded by signs or symptoms sug-
gestive of cardiac tamponade or aneurysm rupture. Sudden death was
considered cardiac, but not aorta-related, in the remaining cases.
High CV risk included patients with history of coronary artery disease
or stroke, or aged more than 40 years with at least 1 CV risk factor (hyper-
tension, hypercholesterolemia, diabetes, current smoking habit). ACS-like
electrocardiogram abnormalities were defined as previously described.11,12
Glomerular filtration rate was estimated using the modifiedModification of
Diet in Renal Disease equation.13 Cardiac troponin was measured with a
standard assay up to 2010 and with a high-sensitivity assay thereafter.
Statistical Analysis
Categoric variables are expressed as number and percentage; contin-
uous variables are expressed as mean  standard deviation or median
and interquartile range. Categoric variables were compared with the chi-
square test or Fisher exact test in cases of a small number of events.
Shapiro–Wilk W test was performed to assess normality distribution of
continuous variables, and then comparisons were performed with the Stu-
dent t test or Mann–Whitney test accordingly. The Kaplan–Meier methoddiovascular Surgery c Volume 156, Number 5 1777




was used to analyze the occurrence of death (log-rank test for curves com-
parison), and Cox regression analysis was performed to identify predictors
of mortality. Major aorta-related events, CV, and other nonaorta-related
events were evaluated with cumulative incidence function with death as
competing risk (Pepe and Mori test for curves comparison), and competing
risk regressions were used to identify long-term predictors. Regarding Cox
regression model, proportional-hazards assumption was evaluated on the
basis of Schoenfeld residuals. For other events (aorta related, nonaorta
related, CV nonaorta related), the proportional-subhazards assumption in
competing risk regression was tested ensuring that coefficients were time
invariant. All variables tested at the univariable analysis were included in
the initial multivariable model, 1-by-1 tested, and eventually excluded ac-
cording to P and chi-square values of the subsequent models. All statistical
analyses were performed using Stata/SE 14.2 (StataCorp LP, College Sta-
tion, Tex).RESULTS
Study Population and Histopathologic Findings
A total of 257 patients with type AAASwere considered;
218 (85%) underwent surgical treatment during the index
hospitalization. Surgical specimens for histology were
available for 158 patients who constituted our study popu-
lation (Figure E2). Baseline histopathologic characteristics
are reported in Table 1. Patients with unavailable aortic
specimens (60) had similar baseline characteristics to those
included in the study (Table E1). All surgical specimens
showed MD, and this was severe in 38 patients (24%).
The most frequent degenerative abnormalities were EFFL
(153 patients, 98.7%), EFT (145 patients, 92.8%), and I-








Not significant 70 (44.3)
Degenerative lesions, (%) 158 (100)
I-MEMA 129 (81.6)
Moderate/severe I-MEMA 93 (58.9)
T-MEMA 108 (68.4)
Moderate/severe T-MEMA 108 (68.4)
Laminar medial collapse 75 (47.5)
Dense laminar medial collapse 59 (37.3)
Elastic fiber thinning out 145 (92.8)
Moderate/severe elastic fiber thinning out 108 (68.4)
Elastic fiber fragmentation 153 (98.7)
Moderate/severe elastic fiber fragmentation 117 (74)
Intralamellar collagen increase 117 (74)
Moderate/severe intralamellar collagen increase 23 (14.6)
Translamellar collagen increase 30 (19)
Moderate/severe translamellar collagen increase 18 (11.4)
Overall severe degenerative 38 (24)
NA, Not applicable; I-MEMA, intralamellar-mucoid extracellular matrix accumulation; T-
1778 The Journal of Thoracic and Cardiovascular Suratherosclerosis (any grade) was documented in 88 patients
(55.7%) and was moderate or severe in 36 patients
(22.8%). Patients with coexisting moderate-severe athero-
sclerosis constituted the mixed degenerative-
atherosclerotic group, renamed ‘‘mixed’’ for simplicity.
Therefore, the study population was divided accordingly
into 2 groups: 122 patients (77.2%) with exclusively degen-
erative abnormalities and 36 patients (22.8%) with mixed
degenerative-atherosclerotic findings (Figure 2).
Comparing the 2 groups, MEMA, especially intralamel-
lar, was the single abnormality that most characterized the
degenerative group; the most frequent alteration in the
mixed group was TCI. LMC was found in 61 patients
(50%) in the degenerative group and in 14 patients
(38.9%) in the mixed group. Among the mixed group,
this abnormality was mainly (13/14) present as a dense
band of elastic fiber compaction bordering the lower
margin of atherosclerotic plaque. In degenerative patients,
LMC was usually found in the central areas of the medial
layer above or on the same level as the dissection
(Figure E3).
Clinical Findings
Baseline clinical characteristics of the study popula-
tion are reported in Table 2. A total of 147 patients
(93%) were diagnosed with acute aortic dissection, and
the remaining 11 patients (7%) were diagnosed with in-
tramural hematoma. The mean age of patients wasbgroups defined by histology
Degenerative
(n ¼ 122, 77.2%)
Mixed
(n ¼ 36, 22.8%) P value
52 (42.6) 36 (100) NA
0 (0) 8 (22.2) NA
0 (0) 28 (77.8) NA
52 (42.6) 0 (0) NA
70 (57.4) 0 (0) NA
122 (100) 36 (100) 1
105 (86) 24 (66.7) .017
80 (65.6) 13 (36.1) .002
88 (72.1) 20 (55.6) .094
88 (72.1) 20 (55.6) .094
61 (50) 14 (38.9) .325
46 (37.7) 13 (36.1) .982
115 (94.3) 30 (83.3) .08
87 (71.3) 21 (58.3) .205
117 (95.9) 36 (100) .489
91 (74.6) 26 (72.2) .945
93 (76.2) 24 (66.7) .35
17 (13.9) 6 (16.7) .788
12 (9.8) 18 (50) <.001
5 (4) 13 (36.1) <.001
32 (26.2) 6 (16.7) .274
MEMA, translamellar-mucoid extracellular matrix accumulation.
gery c November 2018
FIGURE 1. Microscopic images illustrating the most frequently found degenerative lesions. A and B, Aortic dissection in a patient with Marfan syndrome
showing severe EFFL around the false lumen (arrows). A, Weigert Van Gieson, original magnification 325; (B), detail of elastic fiber fragmentation
(arrows). Weigert Van Gieson, original magnification 3100. C and D, Full-thickness aortic specimen with an area of elastic fiber rarefaction in the outer
medial layer (C, arrow: Weigert Van Gieson, original magnification325); the detail shows thinning out of elastic fibers and enlarged spaces between them
(D, Weigert Van Gieson, original magnification 3400). E and F, Examples of intralamellar-mucoid extracellular matrix accumulation. There is mild
(E, 3100) to moderate (B, 3200) enlargement of intralamellar spaces containing bluish-pink mucoid material (hematoxylin–eosin stain).






63.9 years, and 68% were male. Among CV risk factors,
hypertension was the most prevalent (114 patients,
72.2%). A history of coronary artery disease and stroke
was present in 11 patients (7%) and 5 patients (3.2%),
respectively. Marfan syndrome and bicuspid aortic valve
coexisted in 2 patients (1.3%) and 6 patients (3.8%),
respectively.
Clinico-Pathological Correlations
Patients in the mixed group were older (69.6  8.7 years
vs 62.2 12.4 years, P¼ .001) and had a higher prevalence
of hypercholesterolemia compared with those in the degen-
erative group (33.3% vs 13.9%, P ¼ .017). In addition, theThe Journal of Thoracic and Carclinical presentation of patients in the mixed group was
more often characterized by chest pain and ACS-like elec-
trocardiogram abnormalities (38.9% vs 19.7%, P ¼ .032)
(Table 2).
The comparison between patients with dissection (147)
and patients with intramural hematoma (10) did not show
differences in the histopathologic diagnostic category.
However, patients with dissection presented a higher per-
centage of T-MEMA (70.7% vs 36,4%, P¼ .001), whereas
intramural hematoma was strongly associated with athero-
sclerotic lesions (90.9% vs 53.1%, P ¼ .023) (Table E2).
Both patients with a diagnosis of Marfan syndrome were
included in the degenerative group with severeMD in 1 casediovascular Surgery c Volume 156, Number 5 1779
FIGURE 2. A and B, Aortic dissection samples from pure degenerative cases. A, A 45 year-old man with mild MD (hematoxylin–eosin, original magni-
fication325). B, A 54-year-old man with bicuspid aortic valve and severe MD (B, Weigert Van Gieson stain, original magnification325). C and D, Aortic
specimens from the mixed group. The dissection is above the atherosclerotic lesions, and the underlying media shows multifocal elastic fiber fragmentation
(C, arrows) and translamellar (D, arrow) collagen increase (Azan Mallory trichrome, original magnification 325).




and moderate MD in the other. No atherosclerosis was
found in these patients.
Of the 6 patients with bicuspid aortic valve, 5 had purely
degenerative abnormalities—3 had moderate degenerative
abnormalities, 2 had mild and severe degenerative abnor-
malities, and 1 had mixed abnormalities (with moderate
MD).
Patients with ascending aorta diameter 55 mm or greater
at presentation had a more severe overall MD compared
with patients with a diameter less than 55 mm (51.7%
[15/29] vs 12.3% [7/57], P<.001), showing mostly moder-
ate/severe I-MEMA, T-MEMA, and EFT (Table E3).
Patients aged more than 50 years were more frequently
found to have atherosclerotic abnormalities (59.8% [82/
137] vs 28.6% [6/21], P ¼ .014), I-MEMA (83.2% [114/
137] vs 71.4% [15/21], P ¼ .006), and moderate/severe
EFFL (81.7% [112/137] vs 23.8% [5/21], P < .001)
(Table E4).
Figure 3 shows the prevalence of atherosclerosis accord-
ing to age, gender, ascending aorta diameter, and AAS sub-
type according to the DeBakey classification.
Outcome and Prognostic Stratification
In-hospital mortality reached 19% (30 patients) in our
population. A total of 45 patients died during follow-up,1780 The Journal of Thoracic and Cardiovascular Surwith an all-cause mortality at 1, 3, and 6 years of 23%,
26%, and 33%, respectively. The cause of death was aorta
related in 22 patients (postoperative complications in 21
cases, 1 patient died after reintervention for severe aortic
regurgitation during follow-up), CV nonaorta-related in 8
patients (1 for ischemic strokes, 3 for hemorrhagic strokes,
2 for endocarditis on prosthetic valve, 1 for sudden cardiac
death, and 1 for cardiogenic shock secondary to ischemic
dilated cardiopathy), and non–CV-related in 15 patients
(cancer in 4, sepsis in 8, and other causes in 3).
Cumulative incidence of major aorta-related events at 1,
3, and 6 years follow-up was 9%, 16%, and 25%, respec-
tively. Cumulative incidence of nonaorta-related events was
31%, 44%, and 64%, respectively. Cumulative incidence
of CV nonaorta-related events was 10%, 17%, and 23%,
respectively.
Figures 4 and 5 show the 6-year clinical outcome ac-
cording to histopathologic characteristics. Patients with
mixed degenerative atherosclerotic abnormalities more
frequently had nonaorta-related events during follow-up
compared with those with degenerative abnormalities
alone (Pepe and Mori test, P ¼ .046) (Figure 5). No differ-
ences were found between these 2 subgroups with respect
to mortality (34 deaths among degenerative patients and 11
among mixed patients at the end of follow-up, log-rankgery c November 2018
TABLE 2. Clinical findings in the overall population and in the subgroups according to histology
Variable Overall (n ¼ 158)
Degenerative
(n ¼ 122, 77.2%)
Mixed
(n ¼ 36, 22.8%) P value
Aortic dissection, (%) 147 (93) 115 (94.3) 32 (88.9) .459
Intramural hematoma, (%) 11 (7) 7 (5.7) 4 (11.1) .273
Plaque rupture-ulceration, (%) 0 (0) 0 (0) 0 (0) 1
DeBakey type I, (%) 111 (70.3) 89 (73) 22 (61.1) .247
Patients’ characteristics, (%)
Age (y), mean  SD 63.9  12 62.2  12.4 69.6  8.7 .001
Male gender 108 (68.4) 80 (65.6) 28 (77.8) .238
Hypertension (history) 114 (72.2) 84 (68.9) 30 (83.3) .136
Hypercholesterolemia 29 (18.4) 17 (13.9) 12 (33.3) .017
Diabetes 6 (3.8) 6 (4.9) 0 (0) .337
Current smoke 31 (19.6) 23 (18.9) 8 (22.2) .639
Marfan syndrome 2 (1.3) 2 (1.6) 0 (0) 1
Bicuspid aortic valve 6 (3.8) 5 (4.1) 1 (2.8) 1
Aortic coarctation 0 (0) 0 (0) 0 (0) 1
Known thoracic-abdominal aortic aneurysm
(surgically treated or not)
13 (8.2) 8 (6.6) 5 (13.9) .174
Previous AAS 2 (1.3) 1 (0.8) 1 (2.8) .404
Previous stroke 5 (3.2) 4 (3.3) 1 (2.8) 1
Coronary artery disease (history) 11 (7) 6 (4.9) 5 (13.9) .127
Clinical features at presentation, (%)
Systolic blood pressure (mm Hg), mean  SD 134.5  37.3 132.6  37.3 141.1  37.1 .231
Back pain 56 (35.4) 42 (34.4) 14 (38.9) .769
Chest pain 117 (74.1) 88 (72.1) 29 (80.6) .426
Migratory pain 16 (10.1) 10 (8.2) 6 (16.7) .203
Abdominal pain 35 (22.2) 27 (22.1) 8 (22.2) 1
CVA at presentation 5 (3.2) 5 (4.1) 0 (0) .589
Peripheral pulse deficit 36 (22.3) 25 (20.5) 11 (30.6) .257
Shock within 12h of admission 28 (14.3) 24 (19.7) 4 (11.1) .322
ACS-like ECG þ chest pain 38 (24.1) 24 (19.7) 14 (38.9) .032
ACS-like ECG 48 (30.4) 32 (26.2) 16 (44.4) .06
Aortic diameters (mm) on imaging at presentation










































Pleural effusion 25 (15.8) 20 (16.4) 5 (13.9) .801
Pericardial effusion 64 (40.5) 49 (40.2) 15 (41.7) .975
Periaortic effusion 13 (8.2) 8 (6.6) 5 (13.9) .174
Moderate/severe aortic regurgitation 61 (38.6) 44 (36.1) 17 (47.2) .311
Cardiac tamponade 19 (12) 15 (12.3) 4 (11.1) 1
Coronary ostia involvement 16 (10.1) 12 (9.8) 4 (11.1) .761
SD, Standard deviation; AAS, acute aortic syndrome; CVA, cerebrovascular accident; ACS, acute coronary syndrome; ECG, electrocardiogram; IQR, interquartile range; GFR,
glomerular filtration rate.
The Journal of Thoracic and Cardiovascular Surgery c Volume 156, Number 5 1781






FIGURE 3. Prevalence of atherosclerotic lesions according to age,
ascending aorta diameter, gender, and DeBakey subtype.




test, P ¼ .574), major aorta-related events (19 events
among degenerative patients and 10 events among mixed
patients at the end of follow-up, Pepe and Mori test,
P ¼ .407), and CV nonaorta-related events (19 events
among degenerative patients and 10 events among mixed
patients at the end of follow-up, Pepe and Mori test,
P ¼ .202).
Tables 3 and 4 report the major clinical and histologic in-
cremental risk factors for 6-year mortality and for 6-year
nonaorta-related events. Age (hazard ratio [HR], 1.03 for
each 1-year increase; 95% confidence interval [CI, 0.99-
1.06]; P ¼ .069, borderline significance) and glomerular
filtration rate less than 60 mL/min/1.73 m2 at presentation
(HR, 2.33; 95% CI, 1.24-4.4; P ¼ .009) were independent
predictors of mortality (Table 3). Nonaorta-related events
were analyzed in detail, and no differences were found ac-
cording to the patients’ CV risk profile (Figure E4). Hyper-
tension (sub-HR, 1.79; 95% CI, 1.01-3.21; P ¼ .047) and
the coexistence of atherosclerotic lesions together with
degenerative abnormalities (sub-HR, 1.65; 95% CI, 0.96-
2.84; P ¼ .068, borderline significance) were found to be
independent risk predictors for nonaorta-related events
(Table 4).DISCUSSION
This is the first study to provide a detailed description of
the histopathologic findings of aortic specimens and their
clinico-pathological correlation from a large unselected
cohort of patients with type A AAS, applying the classifica-
tion and diagnostic criteria from the recent AECVP/SCVP
consensus statements.7,8 The main findings of the study
are as follows: (1) Although degenerative lesions of the
medial layer were present in all specimens, substantial
atherosclerosis coexisted in approximately one quarter.
(2) Patients with mixed degenerative-atherosclerotic abnor-
malities had a coherent clinical risk profile, with a more1782 The Journal of Thoracic and Cardiovascular Surfrequent presentation mimicking ACS and a long-term
follow-up characterized by nonaorta-related events,
including coronary and cerebrovascular events. (3) Histo-
pathologic characterization could help the long-term prog-
nostic stratification of patients after surgical treatment.
The histopathologic substrate of our cohort was heteroge-
neous because of the variable combination, quantitatively
and qualitatively, of degenerative and atherosclerotic le-
sions. All patients showed MD abnormalities: Almost all
cases had elastic fiber abnormalities, including both thin-
ning out and fragmentation; MEMA was present as I-
MEMA in more than 80% of patients and as T-MEMA
(an expression of a more severe mucopolysaccharide accu-
mulation) in 68.4%; collagen increase was present with a
heterogeneous distribution: intralamellar in 74% and trans-
lamellar (ie, fibrosis) in 19% of cases. It is noteworthy that
more than 50% of patients had some degree of atheroscle-
rosis associated with degenerative lesions. Approximately
one quarter of patients had moderate/severe atherosclerosis,
which the AECVP/SCVP statement7 considers a cause of
significant aortic wall damage with consequent weakness.
The comparison between exclusively degenerative or
mixed subgroups reveals differences in the distribution of
mucoid accumulation and fibrosis. I-MEMA was the most
typical lesion in purely degenerative patients, whereas trans-
lamellar collagen was distinctly increased in the mixed
group. Of note, one third of major atherosclerotic plaques
was accompanied by a thick band ofmedial laminar collapse,
which, together with TCI, can probably be considered a final
response to the atherosclerotic plaque penetrating more
deeply into the media. Elastic fiber alterations were present
in the purely degenerative and mixed groups in equal mea-
sure, probably due to the heterogeneity of various causative
conditions, including the aging process. Our only 2 patients
with Marfan syndrome and 5 of 6 patients with bicuspid
aortic valve had moderate/severe degenerative lesions, in
line with the findings of previous studies.14,15
Unlike previously published similar series,2-5 our study
included exclusively patients with AAS. The first 2
published series evaluating clinico-pathological features
of the ascending aorta described 632 and 339 patients3
who underwent surgery for aneurysm or dissection of the
ascending aorta. Compared with our population, the pa-
tients in these series were younger, with a higher prevalence
of connective tissue disorders and a lower prevalence of se-
vere atherosclerosis. MD was the most common histopath-
ologic finding, and an inverse relationship between the
severity of MD and age was found.3 A more recent study
describing 513 patients4 found that connective tissue disor-
ders were most frequently associated with MD, followed by
aging, and no association between bicuspid aortic valve and
MD was found. Severe atherosclerosis was described in an
exiguous number of patients. Again, it should be noted that
the population in this series was younger compared withgery c November 2018
FIGURE 4. Mortality (left) andmajor aorta-related events (right) of patients with type AAASwith degenerative (122 patients, green line) versus mixed (36
patients, blue line) histologic abnormalities. CI, Confidence interval.






ours and that both aneurysms and dissections were consid-
ered. A further study on 338 surgical specimens, including a
few patients with Marfan, found that MD was a common,
age-related, and nonspecific histologic pattern in aortic an-
eurysms and dissections.5 Atherosclerosis was present in
only 10% of patients and was more frequently associated
with aneurysms than dissections.
In our study, atherosclerosis was more frequent than pre-
viously described, and this is probably due to the older age
of our patients. On the other hand, clinical and epidemio-
logic characteristics of our study population were similar
to those of the largest ‘‘real world registry’’ International
Registry of Acute Aortic Dissection.16 In particular, mean
age (63.9 years), prevalence of male gender (68.4%), hy-
pertension (72.2%), and bicuspid aortic valve (3.8%) were
similar, whereas Marfan syndrome was less frequent (1.3%FIGURE 5. Nonaorta-related events (left) and CV non–aorta-related events (rig
versus mixed (36 patients, blue line) histologic abnormalities. CI, Confidence i
The Journal of Thoracic and Carvs 4.7%) probably because of the prophylactic surgery
strategy adopted in our network.
As expected, patients with atherosclerotic lesions had a
higher CV risk profile. In particular, they were older,
male, and hypercholesterolemic. Of note, atherosclerotic le-
sions were more frequent in patients with a diameter of the
ascending aorta less than 55 mm and in type I AAS
compared with type II (borderline significance) (Figure 3).
The long-term outcome of patients with associated
atherosclerosis is characterized by high probability of
nonaorta-related events, including coronary and cerebro-
vascular events and infectious complications, even if no as-
sociation with overall mortality was shown. As
demonstrated by other studies, renal function and age
(borderline significance in our work) were found to be
risk factors for mortality.17 Notably, along withht) of patients with type AAASwith degenerative (122 patients, green line)
nterval.
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TABLE 3. Risk factors for 6-year mortality of surgically treated patients with type A acute aortic syndrome
Variable
Univariable analysis Multivariable analysis
HR (95% CI) P value HR (95% CI) P value
Age (for each 1-y increase) 1.03 (1.01-1.06) .019 1.03 (0.99-1.06) .069
Male gender 0.95 (0.51-1.78) .897
Hypertension (history) 1.16 (0.59-2.31) .653
Hypercholesterolemia 1.22 (0.58-2.54) .587
Diabetes 2.03 (0.62-6.59) .237
Current smoke 0.67 (0.28-1.58) .365
Marfan-BAV 0.33 (0.04-2.46) .285
DeBakey type I 1.9 (0.47-1.71) .75
GFR<60 mL/min/1.73 m2 at presentation 2.66 (1.43-4.95) .002 2.33 (1.24-4.40) .009
Degenerative-atherosclerotic lesions 1.07 (0.54-2.11) .839
Atherosclerosis (for each 1-point increase according to AHA classification) 1.12 (0.98-1.29) .083
Harrell’s C ¼ 0.65; goodness of fit test (score test) ¼ 0.553; AIC ¼ 382; BIC ¼ 388. HR, Hazard ratio; CI, confidence interval; BAV, bicuspid aortic valve; GFR, glomerular
filtration rate; AHA, American Heart Association.




hypertension, the presence of atherosclerotic abnormalities
was a probable risk factor for nonaorta-related events.
Therefore, the knowledge of the histopathologic substrate
underlying AAS may provide additional information to
the level of risk derived from patients’ clinical characteris-
tics alone.
Study Limitations
Because of the monocentric nature of our work, the size
of the study population and relative events are not compara-
ble with international registries. Twenty-seven percent of
aortic specimens among surgically treated patients did not
reach the histology laboratory because of logistic reasons.
Marfan syndrome was less frequent in our study than in
other series probably because of the prophylactic surgeryTABLE 4. Risk factors for 6-year nonaorta-related events of surgically tre
Variable SHR







DeBakey type I 0.84
GFR<60 mL/min/1.73 m2 at presentation 0.67
Degenerative-atherosclerotic lesions 1.83
Atherosclerosis (for each 1-point increase according to AHA
classification)
1.06
AIC ¼ 585.9; BIC ¼ 592.1. SHR, Sub-hazard ratio; CI, confidence interval; BAV, bicuspi
1784 The Journal of Thoracic and Cardiovascular Surstrategy adopted in our network. Although the description
of the histopathologic spectrum, according to the current
AECVP/SCVP classification, in patients with type A AAS
provides robust and new information, the impact of
clinico-pathological correlations is inevitably limited by
the relatively small study population and the few events
during follow-up. Last, because of the retrospective nature
of this study and the emergency clinical setting, availability
of laboratory data and imaging details—both at presenta-
tion and during follow-up—is limited.
CONCLUSIONS
The new AECVP/SCVP classification allows a compre-
hensive description of aortic wall abnormalities, provides
a standardized characterization of MD, and represents aated patients with type A acute aortic syndrome
Univariable analysis Multivariable analysis
(95% CI) P value SHR (95% CI) P value
(0.98-1.03) .426
(0.54-1.44) .611







(1.09-3.07) .022 1.65 (0.96-2.84) .068
(0.95-1.18) .245
d aortic valve; GFR, glomerular filtration rate; AHA, American Heart Association.
gery c November 2018






useful tool for nosography, clinico-pathological correla-
tions, and prognostic information in patients with type A
AAS. Full knowledge of the histopathologic details of pa-
tients who underwent surgery for AAS can lead to better
planning of long-term follow-up, especially regarding pre-
ventive strategies for nonaorta-related events.Conflict of Interest Statement
Authors have nothing to disclose with regard to commercial
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FIGUREE1. Specimens of type A aortic dissection. A, Dissection involves 75% of circumference and the false lumen contains thrombosis; atherosclerotic
plaques are visible in the intima (arrow). B, Aortic sample where dissection is more extensive (90% of circumference) and the aortic wall is extremely
thinned. C and D, Extensive dissection and irregular intimal surface due to some whitish-yellow plaques (arrow).
Patients admitted with  
type A AAS  
(257) 
Surgical intervention  
(218)
Surgical specimen available 
for histology 
(158)
Surgical specimen not 
available for histology 
 (60) 









FIGURE E2. Study flowchart. AAS, Acute aortic syndrome.
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FIGUREE3. A, Severe focus of translamellar mucoid extracellular matrix accumulation in a degenerative group patient (hematoxylin–eosin stain, original
magnification 3200). B, Medial fibrosis (ie, translamellar collagen increase), a distinctive lesion of the mixed group (Azan Mallory trichrome, original
magnification 3200). C and D, laminar medial collapse. In the mixed group, this lesion was frequently found as a dense band of elastic fiber compaction
bordering the lower margin of atherosclerotic plaques (C, arrow; Weigert Van Gieson, original magnification3100); in degenerative patients, the lesion was
frequently seen in the central areas of the medial layer above or on the same plane of the dissection (arrow) (Weigert Van Gieson, original magnification
3100).
FIGURE E4. The 6-year nonaorta-related events of type A AAS accord-
ing to patients’ CV risk profile. High CV risk means patients with history of
coronary artery disease or stroke, or aged 40 years or older with at least 1
CV risk factor (hypertension, hypercholesterolemia, diabetes, current
smoker). CI, Confidence interval.
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TABLE E1. Surgically treated patients with type A acute aortic syndrome with available versus unavailable surgical specimen for histology
Variable Overall (n ¼ 218)
Specimen available
(n ¼ 158, 72.5%)
Specimen unavailable
(n ¼ 60, 27.5%) P value
Aortic dissection, (%) 198 (90.8) 147 (93) 51 (85) .116
Intramural hematoma, (%) 18 (8.3) 11 (7) 7 (11.7) .276
Plaque rupture-ulceration, (%) 2 (0.9) 0 (0) 2 (3.3) .074
DeBakey type I, (%) 147 (67.4) 111 (70.3) 36 (60) .2
Patients’ characteristics, (%)
Age (y), mean  SD 64.4  12.1 63.9  12 65.5  12.4 .385
Men 148 (67.9) 108 (68.4) 40 (66.7) .939
Hypertension (history) 157 (72) 114 (72.2) 43 (71.7) .922
Hypercholesterolemia 43 (19.7) 29 (18.4) 14 (23.3) .526
Diabetes 9 (4.1) 6 (3.8) 3 (5) .709
Current smoke 37 (17) 31 (19.6) 6 (10) .107
Marfan syndrome 3 (1.4) 2 (1.3) 1 (1.7) 1
Bicuspid aortic valve 7 (3.2) 6 (3.8) 1 (1.7) .676
Aortic coarctation 0 (0) 0 (0) 0 (0) 1
Known thoracic-abdominal aortic aneurysm (surgically treated or not) 19 (8.7) 13 (8.2) 6 (10) .788
Previous AAS 3 (1.4) 2 (1.3) 1 (1.7) 1
Previous stroke 9 (4.1) 5 (3.2) 4 (6.7) .263
Coronary artery disease (history) 15 (6.9) 11 (7) 4 (6.7) 1
Clinical features at presentation, (%)
Systolic blood pressure (mm Hg), mean  SD 134.7  38.4 134.5  37.3 135.1  41.9 .932
Back pain 81 (37.2) 56 (35.4) 25 (41.7) .489
Chest pain 161 (73.9) 117 (74.1) 44 (73.3) .948
Migratory pain 24 (11) 16 (10.1) 8 (13.3) .477
Abdominal pain 48 (22) 35 (22.2) 13 (21.7) .916
CVA at presentation 9 (4.1) 5 (3.2) 4 (6.7) .263
Peripheral pulse deficit 48 (22) 36 (22.3) 12 (20) .975
Shock within 12 of admission 39 (17.9) 28 (14.3) 11 (18.3) .926
ACS-like ECG þ chest pain 50 (22.9) 38 (24.1) 12 (20) .649
ACS-like electrocardiogram 62 (28.4) 48 (30.4) 14 (23.3) .389
Aortic diameters (mm) in first imaging examination












































Pleural effusion 37 (17) 25 (15.8) 12 (20) .595
Pericardial effusion 89 (40.8) 64 (40.5) 25 (41.7) .999
Periaortic effusion 26 (11.9) 13 (8.2) 13 (21.7) .012
Moderate/severe aortic regurgitation 86 (39.4) 61 (38.6) 25 (41.7) .797
Cardiac tamponade 28 (12.8) 19 (12) 9 (15) .651
Coronary ostia involvement 21 (9.6) 16 (10.1) 5 (8.3) .801
AAS, Acute aortic syndrome; ACS, acute coronary syndrome; CVA, cerebrovascular accident; ECG, electrocardiogram; GFR, glomerular filtration rate; IQR, interquartile range;
SD, standard deviation.
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TABLE E2. Histopathologic characteristics according to type of acute aortic syndrome
Variable
Overall Dissection Intramural hematoma
P value(n ¼ 158) 93% (n ¼ 147) 7% (n ¼ 11)
Atherosclerosis, (%) 88 (55.7) 78 (53.1) 10 (90.9) .023
Severe 8 (5.1) 6 (4.1) 2 (18.2) .098
Moderate 28 (17.7) 26 (17.7) 2 (18.2) 1
Mild 52 (32.9) 46 (31.3) 6 (54.5) .179
Not significant 70 (44.3) 69 (46.9) 1 (9.1) .023
Degenerative lesions, (%) 158 (100) 147 (100) 11 (100) NA
I-MEMA 129 (81.6) 121 (82.3) 8 (72.7) .425
Moderate/severe I-MEMA 93 (58.9) 90 (61.2) 3 (27.3) .051
T-MEMA 108 (68.4) 104 (70.7) 4 (36.4) .001
Moderate/severe T-MEMA 108 (68.4) 104 (70.7) 4 (36.4) .001
Laminar collapse 75 (47.5) 69 (46.9) 6 (54.5) .757
Dense laminar collapse 59 (37.3) 54 (36.7) 5 (45.4) .747
Elastic fiber thinning out 145 (92.8) 134 (91.2) 11 (100) .601
Moderate/severe elastic fiber thinning out 108 (68.4) 102 (69.4) 6 (54.5) .326
Elastic fiber fragmentation 153 (98.7) 143 (97.3) 10 (90.9) .306
Moderate/severe elastic fiber fragmentation 117 (74) 110 (74.8) 7 (63.6) .477
Intralamellar collagen increase 117 (74) 107 (72.8) 10 (90.9) .291
Moderate/severe intralamellar collagen increase 23 (14.6) 19 (12.9) 4 (36.4) .056
Translamellar collagen increase 30 (19) 27 (18.4) 3 (27.3) .438
Moderate/severe translamellar collagen increase 18 (11.4) 16 (10.9) 2 (18.2) .363
Degenerative group 122 (77.2) 115 (78.2) 7 (63.6) .274
Mixed group 36 (22.8) 32 (21.8) 4 (36.4) .274
Oveall severe degenerative 38 (24) 36 (24.5) 2 (18.2) 1
I-MEMA, Intralamellar-mucoid extracellular matrix accumulation; NA, not applicable; T-MEMA, translamellar-mucoid extracellular matrix accumulation.
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TABLE E3. Histopathologic findings according to aortic diameter at presentation
Variable Overall (n ¼ 86)
Ascending
aorta 55 mm
(n ¼ 29, 33.7%)
Ascending aorta<55 mm
(n ¼ 57, 66.3%) P value
Atherosclerosis, (%) 45 (52.3) 15 (51.7) 30 (52.5) .882
Severe 6 (7) 2 (6.9) 4 (7) 1
Moderate 18 (20.9) 5 (17.2) 13 (22.8) .779
Mild 21 (24.4) 8 (27.6) 13 (22.8) .791
Not significant 41 (47.7) 14 (48.3) 27 (47.4) .882
Degenerative lesions, (%) 86 (100) 29 (100) 57 (100) 1
I-MEMA 62 (72.1) 24 (82.8) 38 (66.7) .187
Moderate/severe I-MEMA 40 (46.5) 19 (65.5) 21 (36.8) .022
T-MEMA 51 (59.3) 23 (79.3) 28 (49.1) .014
Moderate/severe T-MEMA 51 (59.3) 23 (79.3) 28 (49.1) .014
Laminar medial collapse 29 (33.7) 12 (41.4) 17 (29.8) .406
Dense laminar medial collapse 25 (29.1) 11 (37.9) 14 (24.6) .298
Elastic fiber thinning out 77 (89.5) 26 (89.7) 51 (89.5) .729
Moderate/severe elastic fiber thinning out 26 (30.2) 22 (75.9) 4 (7) <.001
Elastic fiber fragmentation 82 (95.3) 29 (100) 53 (93) .358
Moderate/severe elastic fiber fragmentation 57 (66.3) 23 (79.3) 34 (59.6) .114
Intralamellar collagen increase 62 (72.1) 23 (79.3) 39 (68.4) .418
Moderate-severe intralamellar collagen increase 13 (15.1) 5 (17.2) 8 (14) .754
Translamellar collagen increase 16 (18.6) 5 (17.2) 11 (19.3) 1
Moderate-severe translamellar collagen increase 10 (11.6) 3 (10.3) 7 (12.3) 1
Degenerative group 62 (72.1) 22 (75.9) 40 (70.2) .763
Mixed group 24 (27.9) 7 (24.1) 17 (29.8) .622
Overall severe degenerative 21 (24.4) 15 (51.7) 7 (12.3) <.001
I-MEMA, Intralamellar-mucoid extracellular matrix accumulation; T-MEMA, translamellar-mucoid extracellular matrix accumulation.
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TABLE E4. Histopathologic findings in patients aged more than 50 years versus patients aged 50 years or less
Variable Overall (n ¼ 158)
Age>50 y
(n ¼ 137, 86.7%)
Age 50 y
(n ¼ 21, 13.3%) P value
Atherosclerosis, (%)
Severe 8 (5.1) 8 (5.8) 0 (0) .598
Moderate 28 (17.7) 27 (19.7) 1 (4.8) .127
Mild 52 (32.9) 47 (34.3) 5 (23.8) .457
Not significant 70 (44.3) 55 (40.1) 15 (71.4) .014
Degenerative lesions, (%)
I-MEMA 129 (81.6) 114 (83.2) 15 (71.4) .006
Moderate/severe I-MEMA 93 (58.9) 81 (59.1) 12 (57.1) 1
T-MEMA 108 (68.4) 91 (66.4) 17 (80.9) .184
Moderate/severe T-MEMA 108 (68.4) 91 (66.4) 17 (80.9) .216
Laminar medial collapse 75 (47.5) 68 (49.6) 7 (33.3) .240
Dense laminar medial collapse 59 (37.3) 53 (38.7) 6 (28.6) .471
Elastic fiber thinning out 145 (92.8) 129 (94.2) 16 (76.2) .787
Moderate/severe elastic fiber thinning out 108 (68.4) 96 (70.1) 12 (57.1) .313
Elastic fiber fragmentation 153 (98.7) 132 (96.3) 21 (100) .374
Moderate/severe elastic fiber fragmentation 117 (74) 112 (81.7) 5 (23.8) <.001
Intralamellar collagen increase 117 (74) 104 (75.9) 13 (61.9) .187
Moderate-severe intralamellar collagen increase 23 (14.6) 19 (13.9) 4 (19) .513
Translamellar collagen increase 30 (19) 28 (20.4) 2 (9.5) .371
Moderate-severe translamellar collagen increase 18 (11.4) 17 (12.4) 1 (4.8) .471
Degenerative group 122 (77.2) 102 (74.5) 20 (95.2) .047
Mixed group 36 (22.8) 35 (25.5) 1 (4.8) .047
Overall severe degenerative 38 (24) 31 (22.6) 7 (33.3) .284
I-MEMA, Intralamellar-mucoid extracellular matrix accumulation; T-MEMA, translamellar-mucoid extracellular matrix accumulation.
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